Swiss IPOs Can't Compensate for Delisting Trend in Zurich: Chart

Galenica Sante’s stock sale in April may have been one of 2017’s biggest European IPOs, but that’s no reason for the Zurich stock exchange to celebrate. Over the past eight years, more companies have decided to leave the exchange than new ones to join. While Zur Rose Group AG is set to start trading July 6 and Landis+Gyr may also seek an IPO, acquisitions will lead to the delisting of heavyweights including Actelion Ltd. and Syngenta AG.

    Before it's here, it's on the Bloomberg Terminal.
    LEARN MORE